Luis Augusto Juncos
Adjunct Professor of Medicine
Also affiliated: University Health Network (2019); Mayo Clinic (1997–2026); University of British Columbia (2019); University of Miami (2024); Consejo Nacional de Investigaciones Científicas y Técnicas (2010–2012); Minnesota State University, Mankato (2000); Henry Ford Health (1993–1998); Shandong University (2016); Universidad Nacional de Córdoba (1999–2015); Chinese Academy of Medical Sciences & Peking Union Medical College (2017); University of South Florida (2016–2017); AdventHealth Orlando (2021–2023); University of Arkansas Medical Center (2021); University of Florida Health (2008); Henry Ford Hospital (1991–2009); University of Mississippi Medical Center (2000–2019); University of Alabama at Birmingham (2013); University of Florida (2008); University of Mississippi (2011–2015); NYU Langone Health (2019); Central Arkansas Veterans Healthcare System (2018–2025); United States Army Institute of Surgical Research (2008); Fresenius Medical Care (United States) (2025–2026); G.V. (Sonny) Montgomery VA Medical Center (2012); John L. McClellan Memorial Veterans Hospital (2019–2021); Fu Wai Hospital (2017); State Key Laboratory of Cardiovascular Disease (2017); Fresenius Medical Care North America (United States) (2025–2026); New York University (2019); Zhejiang University (2016); Columbia University (2019); Universidad de Murcia (2000–2005); Fresenius Medical Care (Germany) (2025)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Luis Augusto Juncos's research has focused on kidney diseases, including acute kidney injury (AKI) and its management, as well as the interplay between obesity, hypertension, and chronic kidney disease. He has investigated treatment options for conditions like membranous nephropathy and lupus nephritis, examining the efficacy of various drug regimens, including rituximab, cyclosporine, azathioprine, prednisone, and heparin. His work also extends to understanding the physiological mechanisms underlying blood pressure regulation, specifically the role of endothelium-derived relaxing factor/nitric oxide in modulating angiotensin II action in renal arterioles. Additionally, Juncos has explored the impact of oxidative stress in conditions such as obstructive sleep apnea and its potential links to cardiovascular health.
Metrics
- h-index: 42
- Publications: 200
- Citations: 5,838
Positions
-
Adjunct Professor of Medicine 2024–presentUniversity of Arkansas for Medical Sciences Medicine ORCID
-
Senior Director Critical Care 2024–presentFresenius Medical Care (United States) Medical Affairs ORCID
-
Chief of Nephrology 2018–2024Central Arkansas Veterans Healthcare System Medicine ORCID
-
Professor of Medicine 2018–2024University of Arkansas for Medical Sciences Medicine ORCID
-
Chief of Nephrology / Professor of Medicine, Physiology and Biophysics 2007–2018University of Mississippi Medical Center Medicine ORCID
-
Physician/Scientist 1996–2007Mayo Clinic Minnesota Medicine ORCID
-
Physician Scientist 1988–1996Henry Ford Hospital Medicine ORCID
Selected Publications
-
Aldosterone in Diabetic Kidney Disease: From Mineralocorticoid Receptor Antagonism to Aldosterone Synthase Inhibition (2026)
-
185: IS LIPOPROTEIN (A) AN INDEPENDENT PREDICTOR FOR CARDIOGENIC SHOCK? (2026)
-
Guilty or Not Guilty (2026)
-
The Aging Kidney and Acute Kidney Injury (2025)
-
Evaluating Real-World Data of CRRT Dose Prescription: Results from the CRRTnet Registry (2025)
-
NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury (2025)
-
Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy (2025)
-
From Receptor to Repair (2025)
-
The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury (2025)
-
ACE2 deficiency protects against heme protein-induced acute kidney injury (2025)
-
The Occurrence of Senescence in the Arteriovenous Fistula in the Rat (2024)
-
Semaglutide (Ozempic), a Possible Cause of Focal Segmental Glomerulosclerosis (FSGS) (2023)
-
Nrf2 Activation in the Glomeruli and Podocytes: Deciphering the Renal Mechanisms of Nrf2 (2023)
-
SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery (2023)
-
High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: CON (2023)
Collaboration Network
Top Collaborators
- Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study
- Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward
- Vascular access, membranes and circuit for CRRT
- Point-of-Care Ultrasound in Acute Care Nephrology
- Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation
Showing 5 of 9 shared publications
- Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
- Autophagy Function and Regulation in Kidney Disease
- Angiotensin‐(1‐7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb
- Vascular access, membranes and circuit for CRRT
- Point-of-Care Ultrasound in Acute Care Nephrology
Showing 5 of 8 shared publications
- Quality Improvement Goals for Acute Kidney Injury
- Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference
- Pathophysiology of Acute Kidney Injury in Critical Illness: A Narrative Review
- Pathophysiology of Acute Kidney Injury in Critical Illness: A Narrative Review
- Quality Improvement Goals for Acute Kidney Injury
- Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference
- Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study
- Evaluating Real-World Data of CRRT Dose Prescription: Results from the CRRTnet Registry
- Quality Improvement Goals for Acute Kidney Injury
- Quality of care and safety measures of acute renal replacement therapy: Workgroup statements from the 22nd acute disease quality initiative (ADQI) consensus conference
- Epidemiology and Outcomes of AKI Treated With Continuous Kidney Replacement Therapy: The Multicenter CRRTnet Study
- Evaluating Real-World Data of CRRT Dose Prescription: Results from the CRRTnet Registry
- Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis
- Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study
- Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward
- Author Correction: Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- The Role of Esm-1 in Diabetic Kidney Disease: More Than Just a Biomarker
- The Occurrence of Senescence in the Arteriovenous Fistula in the Rat
- ACE2 deficiency protects against heme protein-induced acute kidney injury
- NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury
- The Aging Kidney and Acute Kidney Injury
- The Occurrence of Senescence in the Arteriovenous Fistula in the Rat
- ACE2 deficiency protects against heme protein-induced acute kidney injury
- NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury
- The Aging Kidney and Acute Kidney Injury
- The Occurrence of Senescence in the Arteriovenous Fistula in the Rat
- ACE2 deficiency protects against heme protein-induced acute kidney injury
- NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury
- The Aging Kidney and Acute Kidney Injury
- Quality Improvement Goals for Acute Kidney Injury
- Urinary NGAL as a Diagnostic and Prognostic Marker for Acute Kidney Injury in Cirrhosis: A Prospective Study
- Terlipressin and the Treatment of Hepatorenal Syndrome: How the CONFIRM Trial Moves the Story Forward
- SOD1 is a novel prognostic biomarker of acute kidney injury following cardiothoracic surgery
- Plasma Cell–Directed Rescue With Bortezomib in Refractory Antiphospholipase A2 Receptor–Positive Membranous Nephropathy
- The role of IGFBP-1 in the clinical prognosis and pathophysiology of acute kidney injury
- The Occurrence of Senescence in the Arteriovenous Fistula in the Rat
- ACE2 deficiency protects against heme protein-induced acute kidney injury
- NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury
- The Occurrence of Senescence in the Arteriovenous Fistula in the Rat
- ACE2 deficiency protects against heme protein-induced acute kidney injury
- NAD+-Boosting Ameliorates Heme Protein–Mediated Acute Kidney Injury
- Anticoagulación en terapia de reemplazo renal continua
- Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America
Similar Researchers
Based on overlapping research topics